"Currently available data show that vaccination remains the best defense against severe disease, hospitalization, and death caused by COVID-19 across all age groups." ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least ...

The FDA authorized Pfizer's omicron booster shot for kids younger than five who were previously vaccinated with three doses ...

bivalent COVID-19 vaccine as a single booster dose in certain children. The amended authorization is for children six months through four years of age who have completed their initial three-dose ...

In December 2022, the FDA authorized the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to be given as the third dose in the primary series for children in this age group, who already received the ...

the FDA announced on Tuesday. Kids ages 6 months to 4 years who completed their primary vaccination with three doses of the monovalent Pfizer-BioNTech shot can now get a booster with the companies' ...

U.S. FDA Expands Authorization of Pfizer Bivalent COVID-19 Shots in Kids (Reuters) - Pfizer Inc said on Tuesday that the U.S. Food and Drug Administration had expanded the emergency use ...

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, ...

(RTTNews) - The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age. In a statement, the ...